Crystalline forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3 (4 -ethoxybenzyl)phenyl)-6-(methylthio) tetrahydro-2h- pyran-3, 4, 5 -triol and pharmaceutical compositions comprising them
Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.